Julien Blouin

Stock Analyst at Goldman Sachs

(3.19)
# 1,089
Out of 5,126 analysts
28
Total ratings
57.14%
Success rate
1.73%
Average return

Stocks Rated by Julien Blouin

UDR, Inc.
Jan 20, 2026
Maintains: Sell
Price Target: $33$38
Current: $37.55
Upside: -0.13%
Healthpeak Properties
Jan 9, 2026
Initiates: Neutral
Price Target: $17
Current: $16.85
Upside: +0.89%
Jones Lang LaSalle
Nov 26, 2025
Maintains: Buy
Price Target: $361$407
Current: $342.76
Upside: +18.74%
Camden Property Trust
Sep 17, 2025
Downgrades: Sell
Price Target: $118$106
Current: $106.63
Upside: -0.59%
American Homes 4 Rent
Sep 17, 2025
Downgrades: Neutral
Price Target: $43$37
Current: $30.84
Upside: +19.97%
Cushman & Wakefield
Aug 13, 2025
Maintains: Buy
Price Target: $18$20
Current: $16.16
Upside: +23.76%
Millrose Properties
May 15, 2025
Maintains: Buy
Price Target: $28$32
Current: $31.69
Upside: -0.60%
Invitation Homes
May 6, 2025
Maintains: Buy
Price Target: $39$43
Current: $26.34
Upside: +63.25%
Newmark Group
Mar 19, 2025
Maintains: Buy
Price Target: $20$17
Current: $16.87
Upside: +0.80%
Colliers International Group
Mar 19, 2025
Maintains: Neutral
Price Target: $165$145
Current: $139.72
Upside: +3.78%
Initiates: Buy
Price Target: $176
Current: $169.67
Upside: +3.73%
Initiates: Neutral
Price Target: $318
Current: $258.06
Upside: +23.23%
Initiates: Neutral
Price Target: $81
Current: $63.89
Upside: +26.78%
Initiates: Buy
Price Target: $187
Current: $132.13
Upside: +41.53%